207 related articles for article (PubMed ID: 26833069)
1. US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.
Kim MJ; Su MY; Yu HJ; Chen JH; Kim EK; Moon HJ; Choi JS
BMC Cancer; 2016 Feb; 16():50. PubMed ID: 26833069
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
[TBL] [Abstract][Full Text] [Related]
3. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
4. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
7. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the dynamic contrast-enhanced MRI features and prognostic factors in breast cancer: A retrospective case-control study.
Tao W; Hu C; Bai G; Zhu Y; Zhu Y
Medicine (Baltimore); 2018 Jul; 97(28):e11530. PubMed ID: 29995825
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.
Ma L; Xu X; Zhang M; Zheng S; Zhang B; Zhang W; Wang P
Magn Reson Imaging; 2017 Apr; 37():27-32. PubMed ID: 27840273
[TBL] [Abstract][Full Text] [Related]
10. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
[TBL] [Abstract][Full Text] [Related]
11. Diffuse optical tomography of breast carcinoma: can tumor total hemoglobin concentration be considered as a new promising prognostic parameter of breast carcinoma?
Xiao M; Jiang Y; Zhu Q; You S; Li J; Wang H; Lai X; Zhang J; Liu H; Zhang J
Acad Radiol; 2015 Apr; 22(4):439-46. PubMed ID: 25753593
[TBL] [Abstract][Full Text] [Related]
12. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
[TBL] [Abstract][Full Text] [Related]
13. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.
Eby PR; Partridge SC; White SW; Doot RK; Dunnwald LK; Schubert EK; Kurland BF; Lehman CD; Mankoff DA
Acad Radiol; 2008 Oct; 15(10):1246-54. PubMed ID: 18790395
[TBL] [Abstract][Full Text] [Related]
15. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
[TBL] [Abstract][Full Text] [Related]
16. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
17. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
18. Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.
Nilsen LB; Fangberget A; Geier OM; Engebraaten O; Borgen E; Olsen DR; Seierstad T
J Magn Reson Imaging; 2014 Dec; 40(6):1382-91. PubMed ID: 24470360
[TBL] [Abstract][Full Text] [Related]
19. US-guided optical tomography: correlation with clinicopathologic variables in breast cancer.
Choi JS; Kim MJ; Youk JH; Moon HJ; Suh HJ; Kim EK
Ultrasound Med Biol; 2013 Feb; 39(2):233-40. PubMed ID: 23219038
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Enhanced Magnetic Resonance Imaging versus Ultrasonic Diffused Optical Tomography in Early Diagnosis of Breast Cancer.
Xue F; Jiang J
J Healthc Eng; 2022; 2022():4834594. PubMed ID: 35449832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
